DE60013859D1 - Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis - Google Patents

Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis

Info

Publication number
DE60013859D1
DE60013859D1 DE60013859T DE60013859T DE60013859D1 DE 60013859 D1 DE60013859 D1 DE 60013859D1 DE 60013859 T DE60013859 T DE 60013859T DE 60013859 T DE60013859 T DE 60013859T DE 60013859 D1 DE60013859 D1 DE 60013859D1
Authority
DE
Germany
Prior art keywords
osteoporosis
treating
indolder derivatives
indolder
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60013859T
Other languages
English (en)
Other versions
DE60013859T2 (de
Inventor
Carlo Farina
Stefania Gagliardi
A Novella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NiKem Research SRL
Original Assignee
NiKem Research SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NiKem Research SRL filed Critical NiKem Research SRL
Application granted granted Critical
Publication of DE60013859D1 publication Critical patent/DE60013859D1/de
Publication of DE60013859T2 publication Critical patent/DE60013859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
DE60013859T 1999-06-18 2000-06-16 Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis Expired - Lifetime DE60013859T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914371.1A GB9914371D0 (en) 1999-06-18 1999-06-18 Novel compounds
GB9914371 1999-06-18
PCT/EP2000/005672 WO2001002388A1 (en) 1999-06-18 2000-06-16 Indole derivatives and their use for the treatment of osteoporosis amongst other applications

Publications (2)

Publication Number Publication Date
DE60013859D1 true DE60013859D1 (de) 2004-10-21
DE60013859T2 DE60013859T2 (de) 2005-09-29

Family

ID=10855696

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60013859T Expired - Lifetime DE60013859T2 (de) 1999-06-18 2000-06-16 Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis

Country Status (30)

Country Link
US (2) US6787550B1 (de)
EP (1) EP1212317B1 (de)
JP (1) JP2003503490A (de)
KR (1) KR100701109B1 (de)
CN (1) CN1179960C (de)
AR (1) AR024390A1 (de)
AT (1) ATE276245T1 (de)
AU (1) AU768726B2 (de)
BR (1) BR0011708A (de)
CA (1) CA2376657A1 (de)
CO (1) CO5200757A1 (de)
CZ (1) CZ301697B6 (de)
DE (1) DE60013859T2 (de)
DK (1) DK1212317T3 (de)
ES (1) ES2226870T3 (de)
GB (1) GB9914371D0 (de)
GC (1) GC0000341A (de)
HK (2) HK1048468B (de)
HU (1) HUP0202049A3 (de)
IL (2) IL147012A0 (de)
MX (1) MXPA01013277A (de)
MY (1) MY129425A (de)
NO (1) NO322313B1 (de)
NZ (1) NZ516131A (de)
PL (1) PL352964A1 (de)
PT (1) PT1212317E (de)
TR (1) TR200103683T2 (de)
TW (1) TWI248440B (de)
WO (1) WO2001002388A1 (de)
ZA (1) ZA200200177B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615575B2 (en) 2003-02-13 2009-11-10 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
WO2005009993A1 (en) * 2003-07-15 2005-02-03 Smithkline Beecham Corporation Novel compounds
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
KR101242962B1 (ko) 2004-09-17 2013-03-13 아이데닉스 파마슈티칼스, 인코포레이티드 Ｈｉｖ 억제제로서의 포스포인돌
EP2813498B1 (de) * 2004-10-04 2016-04-20 Manfredi, John Verbindungen gegen Alzheimerkrankheit
US7833805B2 (en) * 2004-10-21 2010-11-16 University Of Cincinnati Selectively permeable membranes on porous substrates
WO2007010723A1 (ja) * 2005-07-20 2007-01-25 National University Corporation Kanazawa University トリプトファン誘導体及びその用途
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
RU2385865C2 (ru) * 2005-08-15 2010-04-10 Айрм Ллк Соединения и композиции в качестве миметиков тро
EP1779848A1 (de) * 2005-10-28 2007-05-02 Nikem Research S.R.L. V-atpase Inhibitoren zur Behandlung von Entzündungserkrankungen und Autoimmunerkrankungen
EP1779849A1 (de) * 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase Inhibitoren zur Behandlung von septischem Schock
CA2637373A1 (en) 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7820721B2 (en) 2006-01-25 2010-10-26 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
AU2007212104A1 (en) 2006-02-02 2007-08-16 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP2009543805A (ja) * 2006-07-13 2009-12-10 スミスクライン ビーチャム コーポレーション インドリン誘導体及びｇｐｒ１１９作動物質
WO2008042240A2 (en) 2006-09-29 2008-04-10 Idenix Pharmaceuticals, Inc. Enantiomerically pure phosphoindoles as hiv inhibitors
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
MX2011008601A (es) 2009-02-16 2011-09-09 Giuliani Int Ltd Compuestos de alquilamido y usos de los mismos.
US20110038852A1 (en) * 2009-06-10 2011-02-17 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels
RS53844B1 (en) * 2010-09-08 2015-08-31 Bristol-Myers Squibb Company NEW PIPERAZINE ANALYSIS AS A WIDER ANTI-VIRUS MEDICINE AGAINST VIRUS INFLUENCE
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
US20120142627A1 (en) * 2010-12-06 2012-06-07 Emory University Monophosphate prodrugs of dapd and analogs thereof
CN104254327A (zh) 2012-02-09 2014-12-31 诺格拉制药有限公司 治疗纤维化的方法
IN2014DN08157A (de) 2012-04-18 2015-05-01 Nogra Pharma Ltd
KR20210125047A (ko) 2019-02-08 2021-10-15 노그라 파마 리미티드 3-(4'-아미노페닐)-2-메톡시프로피온산, 및 그의 유사체 및 중간체의 제조 방법
CN113024432A (zh) * 2019-12-24 2021-06-25 上海科胜药物研发有限公司 一种氨磺必利药典杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
BR9606743A (pt) * 1995-01-10 1997-12-30 Smithkline Beecham Spa Derivados indol úteis no tratamento de osteoporose
ES2229375T3 (es) * 1996-07-09 2005-04-16 Nikem Research S.R.L. Derivados del indol para el tratamiento de la osteoporosis.
ATE288909T1 (de) * 1997-12-24 2005-02-15 Nikem Research Srl Indolderivate verwendbar zur behandlung von u.a. osteoporosis

Also Published As

Publication number Publication date
AU768726B2 (en) 2004-01-08
CZ20014496A3 (cs) 2002-07-17
MXPA01013277A (es) 2002-06-04
DE60013859T2 (de) 2005-09-29
CZ301697B6 (cs) 2010-05-26
KR100701109B1 (ko) 2007-03-29
ZA200200177B (en) 2003-09-23
ATE276245T1 (de) 2004-10-15
PL352964A1 (en) 2003-09-22
BR0011708A (pt) 2002-05-21
HK1049164A1 (zh) 2003-05-02
IL147012A (en) 2007-06-03
CN1370159A (zh) 2002-09-18
TR200103683T2 (tr) 2003-01-21
HK1048468A1 (en) 2003-04-04
CO5200757A1 (es) 2002-09-27
US6787550B1 (en) 2004-09-07
HUP0202049A2 (hu) 2002-11-28
CN1179960C (zh) 2004-12-15
PT1212317E (pt) 2005-02-28
EP1212317A1 (de) 2002-06-12
NO322313B1 (no) 2006-09-11
NO20016149L (no) 2001-12-17
HUP0202049A3 (en) 2003-12-29
JP2003503490A (ja) 2003-01-28
CA2376657A1 (en) 2001-01-11
TWI248440B (en) 2006-02-01
IL147012A0 (en) 2002-08-14
MY129425A (en) 2007-03-30
AR024390A1 (es) 2002-10-02
GB9914371D0 (en) 1999-08-18
DK1212317T3 (da) 2005-01-24
ES2226870T3 (es) 2005-04-01
EP1212317B1 (de) 2004-09-15
NO20016149D0 (no) 2001-12-17
WO2001002388A1 (en) 2001-01-11
US20040235930A1 (en) 2004-11-25
NZ516131A (en) 2003-10-31
GC0000341A (en) 2007-03-31
HK1048468B (zh) 2005-07-29
KR20020025079A (ko) 2002-04-03
AU5816500A (en) 2001-01-22

Similar Documents

Publication Publication Date Title
DE60013859D1 (de) Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE438630T1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
NO20012160L (no) Anordning for behandling av makuladegenerasjon
BR9803500B1 (pt) método e aparelho para tratamento de refugo.
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE69935624D1 (de) Vorrichtung zur Behandlung von Banknoten
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE231686T1 (de) Schädlingsbekämpfungsmittel zur behandlung von saatgut
DE69624699D1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE60038458D1 (de) Verwendung von polymerem material zur behandlung harter oberflächen
ATE259818T1 (de) Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
ATE227278T1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE69936349D1 (de) Vorrichtung zur behandlung von abfällen
DE69900168D1 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
DE69909854D1 (de) Vorrichtung zur Behandlung von festem Abfall
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69828998D1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
DE69904849D1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
ATE300531T1 (de) Isonipecotamide zur behandlung von integrin vermittelten störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition